Marine fatty acid review reports lower triglycerides and some LDL increases
The review reported lower triglycerides and some LDL cholesterol increases, while several other metabolic outcomes lacked enough data for pooling.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review found triglyceride reductions with marine-derived fatty acid supplements, alongside LDL cholesterol increases in some low-dose groups. It examined how results varied by dose and duration, but the abstract does not establish an optimal regimen. Data were insufficient to pool several other metabolic outcomes, so broader health benefits remain uncertain.
The abstract does not define the values following its ± symbols. Several outcomes lacked enough data for meta-analysis, and the conclusions make broader claims about those outcomes than the results can substantiate.
What changed in the trials
Triglycerides fell in several dose and duration groups. LDL cholesterol rose in the short-term and long-term low-dose groups. These are blood measurements; the abstract does not report whether supplementation changed cardiovascular events or diabetes diagnoses.
Where the evidence runs out
The results say there were insufficient data to pool HDL cholesterol, blood glucose, blood pressure and other metabolic measures. That gap cannot establish either a benefit or an absence of effect for those outcomes.
The original publication
Marine-Based Omega-3 Fatty Acids and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Basirat A, Merino-Torres JF
Nutrients · 2025
- PubMed ID
- 41156531
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.